Vancouver, British Columbia--(Newsfile Corp. - April 6, 2026) - Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ("Oracle" or the "Company") announces that, further to its news releases dated March 12, 2026, March 13, 2026 and March 25, 2026, it has closed the second and final tranche of its non-brokered private placement (the "Private Placement"). The Company raised $164,000 through the...
Vancouver, British Columbia--(Newsfile Corp. - April 6, 2026) - Oracle Commodity Holding Corp. (TSXV: ORCL) (OTCQB: ORLCF) ("Oracle" or the "Company") announces that, further to its news releases dated March 12, 2026, March 13, 2026 and March 25, 2026, it has closed the second and final tranche of its non-brokered private placement (the "Private Placement"). The Company raised $164,000 through the sale of 3,280,000 units (each, a "Unit") at a price of $0.05 per Unit. Each Unit consists of one...
SiyueSteuber/iStock Editorial via Getty Images Adobe: One Way Street (Downwards) ADBE price chart (long term, monthly) (TradingView) The mood among Adobe Inc. ( ADBE ) investors right now must be highly depressing. When we consider the long-term chart showing the "one-way street" in its price action, I don't think any of us would disagree. What worries me more is that the decline happened since Q3...
SiyueSteuber/iStock Editorial via Getty Images Adobe: One Way Street (Downwards) ADBE price chart (long term, monthly) (TradingView) The mood among Adobe Inc. ( ADBE ) investors right now must be highly depressing. When we consider the long-term chart showing the "one-way street" in its price action, I don't think any of us would disagree. What worries me more is that the decline happened since Q3 of 2024, suggesting a multi-year digestion of its premium multiple hasn't been adequately addressed. For now, a near-term bottom appears to be more likely than not. But should investors contemplate returning right now? Adobe: Big AI Spenders Are Looking Elsewhere Winners and losers among AI Spenders (a16z) More intense competitive challenges have already worried Adobe investors. We already know that Figma ( FIG ) and Canva are proving to be more than capable rivals. Right now, they are clearly also attracting higher AI spending among larger enterprise customers at the expense of Adobe. From the above table, we can see why, as ADBE notched a -15% YoY change metric. Of course, there's no need to freak out all of a sudden right now. But these are justified concerns and something that we cannot simply dismiss (no longer). Still, it's helpful to note that Adobe also posted more than $26 billion in ARR recently. So, while the forthcoming threats are real, they don't pose an imminent disruption yet. Figma and Canva threat (The Information) Moreover, while the active user base for Adobe’s smaller peers is growing quickly, Canva ($4B annualized revenue as of the end of 2025) and Figma (>$1 billion for FY2025), this revenue is nowhere close to threatening it yet, right? Hence, even as the market assumes higher implied growth multiples for Canva and Figma, we also have to recognize that all of them face similar disruption risks from pure-play AI LLMs. But for us to suggest that Adobe is surely doomed is too big a call to make, because I haven’t seen that thesis playing out in its cor...
UBS: Trump's Historic Military Budget Request Could Boost Beaten-Down Defense Stocks U.S. defense stocks showed signs of stabilizing in April after tumbling since Operation Epic Fury began in late February and sustaining a Mach bloodbath. The improvement followed Friday's White House proposal to lift military spending sharply, to roughly $1.5 trillion in 2027. UBS analyst Allyson Gordon said Monda...
UBS: Trump's Historic Military Budget Request Could Boost Beaten-Down Defense Stocks U.S. defense stocks showed signs of stabilizing in April after tumbling since Operation Epic Fury began in late February and sustaining a Mach bloodbath. The improvement followed Friday's White House proposal to lift military spending sharply, to roughly $1.5 trillion in 2027. UBS analyst Allyson Gordon said Monday morning that the White House budget request "should help sentiment," which has deteriorated since the U.S.-Iran conflict began. Last week, Gordon asked, " Why is U.S. defense performance lackluster ?" Earlier, the analyst said: Defense stocks are in focus after Trump requested a $1.5 trn FY2027 defense budget on Friday. The headline is positive for the group, though market reaction remains to be determined. On the supportive side, defense stocks have underperformed expectations since the Iran conflict began for several reasons, and the size of the budget request should help sentiment. However, investors remain skeptical that Congress will ultimately pass a $1.5 trn budget, raising the question of whether this is "as good as it gets." Analyst Gavin Parsons outlined the key elements of the proposal and the relative winners and losers. Missiles appear to be a major beneficiary, reinforcing the bullish narrative for RTX. Shipbuilding also stands out as a positive (GD, HII), while the proposed B‑21 reduction was a surprise negative for NOC. That said, investor positioning is likely to reflect continued uncertainty around what ultimately makes it through Congress. From here, the proposal moves to Congress, which must pass a budget by September 30 to avoid a shutdown or continuing resolution at the start of FY2027 (October 1). The iShares U.S. Aerospace & Defense ETF, or ITA, a basket of major U.S. defense firms, initially ramped in the early days of the U.S.-Iran conflict but then dumped into a deep 16% correction from the early March high. By the end of the month, and into lat...
Activist fund MAK Capital , led by Michael A. Kaufman , has urged the leadership of German biotech firm Evotec SE to list its US unit and speed up its cost cutting program after the shares have lost about 85% over the past five years. “We believe a U.S.-listed Just Biologics would command a materially higher valuation, in excess of €1 billion ($1.2 billion), access a deeper investor base, provide ...
Activist fund MAK Capital , led by Michael A. Kaufman , has urged the leadership of German biotech firm Evotec SE to list its US unit and speed up its cost cutting program after the shares have lost about 85% over the past five years. “We believe a U.S.-listed Just Biologics would command a materially higher valuation, in excess of €1 billion ($1.2 billion), access a deeper investor base, provide Just Biologics with a cash infusion and dedicated currency for growth” and help retain talent at the Seattle based firm, MAK Capital said in a letter it sent to Evotec’s leadership earlier this month, according to a filing with the SEC. Evotec shares have fallen roughly 17% this year, giving the company a market value of about €801 million. The company wasn’t immediately available outside regular business hours. READ: Activist Investor MAK Capital Reports 7% Stake in Evotec MAK, which recently revealed a 7% stake in Evotec, also urged the company to expedite its current restructuring program, which MAK said is taking too long to turn the company around. Meaningful margin expansion is not expected until 2027 or later, and MAK, in its letter, said that “risks further deterioration of the company’s strengths.” The activist said that management should begin delivering tangible operating improvements in the second half of this year instead. The fund also proposed to appoint former Novartis and Fresenius executive Wolfgang Hofmann to Evotec’s supervisory board as a replacement for Duncan McHale, whose term expires at the end of the upcoming shareholder meeting. READ: Triton Said to Weigh Takeover Deal for Drug Developer Evotec READ: Halozyme Pulls Bid for Drugmaker Evotec as Discussions Stall
Tax-advantaged accounts like IRAs and 401(k)s are often the backbone of a solid retirement plan, and for good reason. These accounts offer up-front tax breaks on your contributions. And investments in a traditional IRA and 401(k) get to grow tax deferred, so you're not writing the IRS a check for your gains every year. But while it's a good idea to lean on IRAs and 401(k)s to build a retirement ne...
Tax-advantaged accounts like IRAs and 401(k)s are often the backbone of a solid retirement plan, and for good reason. These accounts offer up-front tax breaks on your contributions. And investments in a traditional IRA and 401(k) get to grow tax deferred, so you're not writing the IRS a check for your gains every year. But while it's a good idea to lean on IRAs and 401(k)s to build a retirement nest egg, it's equally important to branch out and look outside of these accounts. If you don't, you may find that you don't have enough control over your savings. Image source: Getty Images. Continue reading
Equity bulls expecting a bumpy ride for US equities to be over soon have a historically favorable seasonal pattern on their side. April tends to be a strong month for stocks, with the S&P 500 Index sporting an average gain of 1.5% since 1990, trailing only November’s 2.2% advance, data compiled by Bloomberg show. One popular theory pins the seasonal dynamic on retail investors — a persistent sourc...
Equity bulls expecting a bumpy ride for US equities to be over soon have a historically favorable seasonal pattern on their side. April tends to be a strong month for stocks, with the S&P 500 Index sporting an average gain of 1.5% since 1990, trailing only November’s 2.2% advance, data compiled by Bloomberg show. One popular theory pins the seasonal dynamic on retail investors — a persistent source of support for US stocks — returning to the market after the mid-month tax deadline. “A lot of it revolves around the liquidity needs of retail heading into Tax Day,” said Dave Lutz , equity sales trader and macro strategist at Jonestrading Institutional Services LLC. “Everybody is probably hunkering down and holding any dry powder until they are through their taxes, and historically afterwards, people get refunds and reinvest.” The S&P 500 has posted an average gain of 0.83% between April 15, the deadline for Americans to file their taxes, and the end of the month, according to data compiled by Barclays Plc going back to 2006. And this year, tax-refund checks hitting consumers’ wallets are up 10% from the same time in 2025, according to the Internal Revenue Service. The dynamic may offer a tailwind for a market trying to regain its footing after a bout of geopolitical and policy anxiety pushed technology megacaps into a correction and the S&P 500 down 5% from its peak. The 500-member index gained 0.3% at 3:32 p.m. on Monday, while the Nasdaq 100 Index advanced 0.5%. Under the hood, buying momentum in the second half of April has been particularly pronounced in the Nasdaq Composite Index and small-cap Russell 2000 Index , according to data from the Stock Trader’s Almanac going back to 1994. However, Christopher Mistal , director of research at the firm, strikes a note of caution: pinning all of that on the tax season only may be premature since investors are likely adjusting their positions ahead of earnings season at around the same time. “Nonetheless, the combination of...
SpaceX and investment bankers will host meetings to pressure-test the Elon Musk -led company’s targeted $2 trillion valuation, a crucial step as it drives toward the largest-ever initial public offering, people familiar with the matter said. Two months after a merger with xAI, senior bankers are poised to begin talks around the rocket, satellite and AI company’s initial public offering, to determi...
SpaceX and investment bankers will host meetings to pressure-test the Elon Musk -led company’s targeted $2 trillion valuation, a crucial step as it drives toward the largest-ever initial public offering, people familiar with the matter said. Two months after a merger with xAI, senior bankers are poised to begin talks around the rocket, satellite and AI company’s initial public offering, to determine if its vaunted valuation will still lure in investors. Its market value is now expected to top $2 trillion , up from expectations of $1.75 trillion less than two weeks ago, people familiar with the matter said. “What you’ve got to be convinced of — and this is what they’ll be working on until this is filed publicly — is continuing to sell the dream and basically there’s nobody that’s been better at selling the dream than Elon Musk,” said David Erickson , an adjunct associate professor at Columbia Business School and a former co-head of global equity capital markets at Barclays Plc . Representatives for SpaceX didn’t immediately respond to requests for comment. Musk appeared to push back on the valuation target of $2 trillion in an April 3 X post , saying “don’t believe everything you read.” At more than $2 trillion, SpaceX would be bigger than all but five of the companies in the S&P 500 Index — Nvidia Corp. , Apple Inc. , Alphabet Inc. , Microsoft Corp. and Amazon.com Inc. Despite generating a fraction of the revenue, its market value would dwarf Meta Platforms Inc. and Musk’s own Tesla Inc. , the two other members of the so-called Magnificent 7 stocks. Such a valuation implies a price-to-sales ratio of more than 100-times on a trailing basis, according to analyst estimates, easily topping that of retail-favorite Palantir Technologies Inc. ’s lofty ratio of roughly 79 times — by far the highest in the S&P 500 Index. Bloomberg Intelligence estimates SpaceX’s rocket launch program and Starlink satellites will generate the majority of its revenue, approaching $20 billion i...